Levy, B. P., Paz-Ares, L. G., Lin, C., Herbert, S., Yang, T., Tolcher, A. W., Lou, Y., Zenke, Y., Cortinovis, D., Felip, E., Domine, M., Leventakos, K., Calvo, E., Horiike, A., Pan, E., Matsubara, K., Jia, X., Chiaverelli, R. A., Chisamore, M. J., Goto, Y. (2025). TROPION-Lung02: Datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) as first-line (1L) therapy for advanced non-small cell lung cancer (aNSCLC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8501